Mark Holodniy

Clinical Focus

• Infectious Disease
• Infectious Diseases

Administrative Appointments

• Member, Medical School Faculty Senate (1999 - 2002)
• Member, Administrative Panel on Biosafety (1995 - 2009)

Honors and Awards

• Divisional Award for Exceptional Contributions in Education in the Division of Infectious Disease, Department of Medicine (2004)
• Infectious Diseases Teaching Award, Division of Infectious Diseases (2004)
• Infectious Diseases Teaching Award, Division of Infectious Diseases (1997)
• HIV Program Clinical Excellence Award, Department of Veterans Affairs (2001)

Professional Education

• Fellowship: SUMC - Graduate Medical Education, CA (1990)
• Board Certification: Internal Medicine, American Board of Internal Medicine (1988)
• Residency: Good Samaritan Regional Medical Center, AZ (1988)
• Internship: Good Samaritan Regional Medical Center, AZ (1986)
• Medical Education: Northwestern Memorial Hospital, IL (1985)

Postdoctoral Advisees

Aarthi Chary, Philip Grant, Patricia Schirmer

Graduate & Fellowship Program Affiliations

• Medicine
• Infectious Diseases

Community & International Work

• Tri-national OPTIMA Trial 

Research Interests

My research program is currently focused in three areas: 1) translational research (HCV/HIV viral evolution and antiviral resistance prevalence and development), 2) HIV/HCV clinical trials (diagnostic assay/medical device, antiretrovirals, ARVs and immunomodulators), and 3) health services research focusing on cost effectiveness of HIV antibody and ARV resistance testing and ARV utilization and clincal outcome.

Publications

• The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS. Nosyk B, Sun H, Bansback N, Guh DP, Li X, Barnett P, Bayoumi A, Griffin S, Joyce V, Holodniy M, Owens DK, Anis AH "Qual Life Res" 2009
• Oseltamivir for treatment and prophylaxis of influenza infection. Schirmer P, Holodniy M "Expert Opin Drug Saf" 2009 ; 3 (8) : 357-71
• A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberkoff MS, Weinberg A, Williams HM, Cheney C, Petrukhin L, Abraham KG, Shaw A, Manoff S, Antonello JM, Green T, Wang Y, Tan C, Keller PM "J Med Virol" 2009 ; 7 (81) : 1310-22
• Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing. Lloyd RM, Burns DA, Huong JT, Mathis RL, Winters MA, Tanner M, De La Rosa A, Yen-Lieberman B, Armstrong W, Taege A, McClernon DR, Wetshtein JL, Friedrich BM, Ferguson MR, O'Brien W, Feorino PM, Holodniy M "J Clin Microbiol" 2009 ; 5 (47) : 1491-6
• Health-Related Quality of Life in a Randomized Trial of Antiretroviral Therapy for Advanced HIV Disease Joyce, V, Barnett PG, Bayoumi A, Griffin SC, Kyriakides TC, Yu W, Sundaram V, Holodniy M, Brown ST, Cameron W, "Journal of Acquired Immune Deficiency Syndromes" 2009 ; 1 (50) : 27-36